ArticleHealth economics review2025

A cost-effectiveness analysis comparing single-inhaler extrafine beclomethasone/formoterol/glycopyrronium bromide against other SITTs in adult patients with uncontrolled asthma in England.

Ioanna Vlachaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.